A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.

Abstract

Hepatoblastoma (HB) is the most common malignant liver tumor in children. Although survival of patients has improved significantly over the last 2 decades, a significant number of patients do not respond to standard chemotherapy. We conducted a pilot study to understand if there was immunophenotypic difference between tumors that respond well to… (More)
DOI: 10.1097/PAI.0000000000000492

Topics

  • Presentations referencing similar topics